Angus Dalgleish | |
|---|---|
 Angus Dalgleish, March 2016 | |
| Born | May 1950 (age 73)[1] Harrow, London, England |
| Alma mater | University College London |
| Employer | St George's, University of London |
| Known for | HIV/AIDS research[2] |
| Political party | UK Independence Party (UKIP) |
| Website | www |
Angus George Dalgleish (born May 1950) FRCP FRCPath FMedSci[2] is a professor of oncology at St George's, University of London, best known for his contributions to HIV/AIDS research.[3][4][5][6] Dalgleish stood in 2015 for Parliament as a UKIP candidate.
Angus George Dalgleish was born in May 1950 in Harrow, London.[1][7][8] Initially educated at the Harrow County School for Boys,[7] Dalgleish received a Bachelor of Medicine, Bachelor of Surgery degree from University College London with an intercalated bachelor's degree in Anatomy.[7]
After various positions in the United Kingdom, Dalgleish joined the Royal Flying Doctor Service in Mount Isa, Queensland, then progressed through positions at various hospitals in Brisbane, Australia, before moving to the Ludwig Institute for Cancer Research in Sydney.[7][8]
After completion of his training, Dalgleish returned to work in the UK in 1984 at the Institute of Cancer Research.[7][8] He is a co-discoverer of the CD4 receptor as the major cellular receptor for HIV.[9] [10][11][12] In 1986, he was appointed to a consulting position at Northwick Park Hospital, in 1991 he was made Foundation Professor of Oncology at St George's, University of London,[7] and in 1994 he was appointed Visiting Professor at the Institute of Cancer Research in London.[13]
In 1997, he founded Onyvax Ltd.,[1] a privately-funded biotechnology company developing cancer vaccines, where he held the position as Research Director;[14] it was dissolved in 2013.[15] Dalgleish is a member of the medical board in Bionor Pharma.[citation needed] Dalgleish is on the scientific advisory board of Immodulon, and has stock options in Immunor AS, a disclosure he made in order to have his research work published.[16][non-primary source needed]
During the COVID-19 pandemic, Dalgleish was a proponent of the lab leak theory.[17]
Dalgleish was a member of the UK Independence Party and stood as a candidate in Sutton & Cheam,[18][19] during the 2015 United Kingdom general election finishing fourth with 10.7% of the vote.[20] Dalgleish campaigned for Leave.EU[21] and appeared on the BBC Radio 4 Today programme presenting the case for Brexit.[22][18][23][24] He was an advocate of Leave Means Leave, a Eurosceptic group.[25]
Dalgleish was elected a Fellow of the Academy of Medical Sciences in 2001[2] and is also a Fellow of the Royal College of Physicians[when?] the Royal College of Pathologists[when?] and a Fellow of the Royal Australasian College of Physicians.[when?][23] His citation on election to FMedSci reads:
Professor Angus Dalgleish is Professor of Oncology at St Georges Hospital Medical School London. He has made seminal observations relating to the virology of HIV. In particular he identified CD4 as a major receptive for HIV in humans, produced the first report of a link between Slim Disease in Africa and HIV infection. He also identified the close correlation between the immune response and the presence of tropical spastic paraparesis in patients infected with the HTLV-1 virus.[2]
In October 2023, following a joint investigation analysing emails leaked in 2022 by Russian hacking group working for the Russian FSB, an article was published by Computer Weekly[26] and Byline Times[27] containing several controversial claims about Angus Dalgleish.
According to Semantic Scholar, Dalgleish has 495 publications, 21,234 citations, and 541 "highly influential citations".[30]
in Special Issue Cancer Immunotherapy and Vaccines Research
